{
  "id": 17200929,
  "title": "AstraZeneca launches US$1.5bil annual savings plan to invest in drug pipeline",
  "url": "https://urgent.news/2026/10/30/astrazeneca-launches-us-1-5bil-annual-savings-plan-to-invest-in-drug",
  "topic": "world",
  "section": "World",
  "published": "2026-10-30T08:13:00.000Z",
  "source": {
    "name": "Free Malaysia Today",
    "slug": "free-malaysia-today",
    "url": "https://www.freemalaysiatoday.com/category/business/2026/10/30/astrazeneca-launches-us-1-5bil-annual-savings-plan-to-invest-in-drug-pipeline"
  },
  "original_language": "en",
  "account": null,
  "summary": "Drugmakers worldwide face growing scrutiny over their research pipelines, as valuations increasingly depend on successful late-stage trials rather than blockbuster drugs nearing patent expiry.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}